What's new? Log in Free sign up

Filing search / Kineta, Inc. / "Oversee"

Search information

Kineta, Inc.

Companies

"Oversee"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

54 results

Newest first Best match first

KANT Kineta, Inc.

Definitive proxy

States) (“PCAOB”). The Audit Committee’s main responsibility is to monitor and oversee this process. The Audit Committee reviewed and discussed our

26 Apr 24

4:00pm

KANT Kineta, Inc.

Research Institute to oversee, identify priorities in and conduct comparative clinical effectiveness research, along with funding for such research; (7 … for the manufacturer’s outpatient drugs to be covered under Medicare Part D; (8) established a new Patient-Centered Outcomes Research Institute to oversee

21 Mar 24

4:06pm

KANT Kineta, Inc.

Definitive proxy

of the Public Company Accounting Oversight Board (United States) (“PCAOB”). The Audit Committee’s main responsibility is to monitor and oversee

28 Apr 23

5:09pm

KANT Kineta, Inc.

programs; (6) created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in and conduct comparative clinical … Patient-Centered Outcomes Research Institute to oversee, identify priorities in and conduct comparative clinical effectiveness research, along with funding

31 Mar 23

4:05pm

KANT Kineta, Inc.

Kineta Completes Reverse Merger with Yumanity Therapeutics

, as applicable, that review, approve and oversee basic and clinical research conducted as the institution participating in the clinical trial

519srsw8e 5q5gszh

Kineta Completes Reverse Merger with Yumanity Therapeutics

Quarterly report

14 Nov 22

8:44am

Prospectus supplement

Registration of securities issued in business combination transactions (amended)

4 Nov 22

4:49pm

Registration of securities issued in business combination transactions (amended)

24 Oct 22

9:14am

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

ixv74noqo4ts 1tvcm

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

Registration of securities issued in business combination transactions

29 Aug 22

12:00am

Quarterly report

4 Aug 22

5:12pm

Business combination disclosure

Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief Scientific Officer

qb89nrvs88f1r5tg

Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief Scientific Officer

c0l0r 72pp80jjj2b

Quarterly report

12 May 22

4:59pm

Definitive proxy

25 Apr 22

4:01pm

24 Mar 22

4:31pm

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.